For over two decades, EMINENT has maintained a robust partnership with Takeda, spanning 21 years. During this time, we have provided Takeda with specialized services such as custom packaging, labeling, and global distribution, tailored to meet their specific needs.
Since 2004, EMINENT has proudly served as the primary contractor for the Division of Allergy, Immunology, and Transplantation (DAIT) at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). In this role, we are actively involved in approximately 35 ongoing studies, contributing to the advancement of research in these critical areas.
Additionally, EMINENT has been an essential sub-contractor to The Emmes Corporation since 2005, providing specialized investigational drug services for the National Institute on Drug Abuse (NIDA). Our work supports various protocols within the NIDA Clinical Trials Network (CTN), playing a key role in facilitating these important clinical trials.
Over the last 17 years, EMINENT has also supported studies for the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), particularly those under the Type 1 Diabetes TrialNet, in partnership with the University of South Florida. As the designated Drug Distribution Center, we manage the distribution of investigational drugs for numerous multi-centered Diabetes TrialNet Studies across the European Union and Australia, ensuring efficient and compliant handling of these critical resources.